Drug therapy for chronic subdural hematoma: Bench to bedside
- 1 October 2018
- journal article
- review article
- Published by Elsevier BV in Journal of Clinical Neuroscience
- Vol. 56, 16-20
- https://doi.org/10.1016/j.jocn.2017.07.034
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Activation of JAK-STAT3 signaling pathway in chronic subdural hematoma outer membranesNeuroscience Letters, 2013
- Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trialThe Lancet, 2009
- Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematomaSurgical Neurology, 2009
- Morphological Aspects of the Traumatic Chronic Subdural Hematoma Capsule: SEM StudiesMicroscopy and Microanalysis, 2007
- Local elevation of the anti-inflammatory interleukin-10 in the pathogenesis of chronic subdural hematomaNeurosurgical Review, 2006
- Increased mRNA Expression of VEGF within the Hematoma and Imbalance of Angiopoietin-1 and -2 mRNA within the Neomembranes of Chronic Subdural HematomaJournal of Neurotrauma, 2005
- Effect of Platelet-Activating Factor Receptor Antagonist, Etizolam, on Resolution of Chronic Subdural Hematoma-A Prospective Study to Investigate Use as Conservative Therapy-Neurologia medico-chirurgica, 2005
- Kallikrein-kinin system in chronic subdural haematomas: its roles in vascular permeability and regulation of fibrinolysis and coagulation.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Immunohistochemical localization of tissue-type plasminogen activator in the lining wall of chronic subdural hematomaSurgical Neurology, 1991
- A more systematic management of subdural hematoma with the aid of CT scanSurgical Neurology, 1981